Immunovia Investor Relations Material
Latest events
Q1 2025
Immunovia
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Immunovia
Access all reports
Immunovia AB, a Swedish diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company was founded in 2007 and is listed on Nasdaq Stockholm First North Premier under the ticker IMMUV. Immunovia focuses on blood markers with an impact on health risk assessment, prevention and drug development.
The tests have the potential to significantly improve doctors' possibilities to predict and prevent people from getting ill. The most advanced applications for our tests are for important risk groups such as breast cancer patients, heart attack cases, or diabetes type 2 sufferers. Immunovia AB is headquartered in Lund, Sweden.
Key slides for Immunovia
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
IMMNOV
Country
🇸🇪 Sweden